News & Analysis on Clinical Trial Services & Contract Research And Development
Video Q&A
CMO consolidation strategy has shifted from building scale and adding geographies towards niche technologies and biologics, according to the founder of trade association PBOA.
Accelerated access
A UK government report on accelerated access to medicines proposes overhauling conditional licensing and reimbursement pathways to drive drug development.
Charles River has reported strong Q3 sales despite weakness in Japan and plans to grab space in emerging early discovery, bio-testing and Chinese markets.
Production has begun at a BASF facility in Germany to help feed the growth in pharma demand for specialty amines.
Gaining a foothold in North America would complete Recipharm’s growth strategy in becoming a global CDMO leader, the firm says.